Kathryn DiMarco
Förmögenhet: 533 062 $ per 2026-08-31
Förmögenhet: 533 062 $ per 2026-08-31
Ms. Kathryn DiMarco is a Senior Vice President-Finance & Controller at Organon & Co. Ms. DiMarco was previously employed as a Controller by Allergan Ltd. (Ireland) and an International Controller by Merck Sharp & Dohme Corp.
She received her undergraduate degree from Lehigh University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ORGANON & CO. 0,01 % | 2025-03-31 | 38 740 ( 0,01 % ) | 533 062 $ | 2026-08-31 |
| Företag | Position | Slut |
|---|---|---|
| ORGANON & CO. | Comptroller/Controller/Revisor | 2025-05-01 |
| ALLERGAN PLC | Comptroller/Controller/Revisor | 2020-01-01 |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Comptroller/Controller/Revisor | 2015-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Organon & Co.
Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån